ClinicalTrials.Veeva

Menu

Reliability and Validity of the French Version of the Virtual Reality Sickness Questionnaire (VRSQ-F)

P

Pôle Saint Hélier

Status

Completed

Conditions

Virtual Reality Cyber Sickness

Treatments

Diagnostic Test: Use of Measurement Instrument

Study type

Interventional

Funder types

Other

Identifiers

NCT06466590
2023-A02468-37

Details and patient eligibility

About

This is a multicenter, controlled, non-randomized interventional clinical study, with minimal risks and constraints, aimed at verifying the reliability of the French version of the VRSQ questionnaire (VRSQ-F) and the validity of the VRSQ-F score by comparing it with the SSQ score.

Enrollment

88 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

For Healthy people :

  • Men or women aged 18 to 65
  • Person affiliated to a social security scheme
  • Healthy person with no particular medical condition
  • Having given their consent to participate in the research

For patients :

  • Men or women aged 18 to 65
  • Persons affiliated to a social security scheme
  • People undergoing regular rehabilitation, walking or in a wheelchair, who can use a virtual reality solution as part of their care.
  • Having given their consent to take part in the research

Exclusion criteria

  • Vestibular and cardiac pathologies, and major visual disorders not compatible with virtual reality rehabilitation
  • Cognitive and language disorders
  • Persons under legal protection
  • Pregnant women
  • MSSQ greater than 15
  • People suffering from photosensitive epilepsy
  • Persons under the influence of medication that may impair drugs or alcohol
  • Participant with an implanted medical device that may be affected by radio waves emitted by compatible third-party equipment (e.g. : Pacemaker)

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

88 participants in 1 patient group

Single Group
Experimental group
Description:
Participants will be asked to use the measurement instrument VRSQ-F on two separate occasions under identical conditions to assess its test-retest reliability and asked to use the SSQ for validity. Each session will involve completing the measurement protocol as specified.
Treatment:
Diagnostic Test: Use of Measurement Instrument

Trial contacts and locations

3

Loading...

Central trial contact

Emilie LEBLONG

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems